Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 National Biotechnology Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wagner, Erik
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Erik Wagner
Favorite
Wang, Kai
GSK plc
(
T1430-01-03
)
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Kai Wang
Favorite
Wang, Rilla Jiansu
University of Toronto
(
M1330-01-08
)
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Rilla Jiansu Wang
Favorite
Warrino, Dominic
KCAS Bioanalytical & Biomarker
(
T1030-01-06
)
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Dominic Warrino
Favorite
Warzak, Denise
Agilent Technologies, Inc.
(
T1430-01-07
)
Importance of Quality Control of In Vitro Transcribed RNA
Denise Warzak
Favorite
Waymouth, Robert
Stanford University
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Robert Waymouth
Favorite
Weitz, Dietmar
Sanofi
(
M1330-01-06
)
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Dietmar Weitz
Favorite
Wells, Hannah
PPD, a part of Thermo Fisher Scientific
(
M1030-01-05
)
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Hannah Wells
Favorite
Wender, Paul
Stanford University
(
T1130-01-05
)
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Paul Wender
Favorite
Wessel, Howard
Noveome Biotherapeutics, Inc.
(
T1330-01-01
)
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Howard Wessel
Favorite
Whitlock, Susan
Merck & Co., Inc.
(
T1130-01-04
)
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Susan Whitlock
Favorite
Woodruff, Mark
Fortis Technologies LImited
(
M1030-01-03
)
Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography
Mark Woodruff
Favorite
Wu, Edward
National Center for Advancing Translational Sciences
(
T1030-01-07
)
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Edward Wu
Favorite
Wu, Kangzeng
Zhejiang University
(
M1130-01-02
)
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Kangzeng Wu
Favorite
Back to Top